Andreas Guentert is currently a Senior Strategic Director for Mid-sized Markets at Johnson & Johnson Innovative Medicine EMEA. They have a strong background in marketing and sales across various therapeutic areas, leveraging their extensive scientific expertise developed during roles in companies like Roche and Kings College London, where they conducted significant research on Alzheimer’s Disease. Previously, at Janssen, they held several leadership positions in oncology, driving product strategy and business development. Andreas holds a PhD in Neurobiology from the University of Basel and an MBA from ESADE Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices